TOP TIERMARKET NEWSWIRE
News & sentiment

KARYOPHARM THERAPEUT (KPTI) — News & AI sentiment

KARYOPHARM THERAPEUT (KPTI) news roundup. 8 stories aggregated over the last 30 days. Average 30-day sentiment is 48.4/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 6 sales totalling $35K — net selling of $35K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
8
avg sentiment 48.4/100
Insider net (90d)
$35K
0 buys · 6 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on KPTI

Jul 21
RBC Capital reiterates Karyopharm stock rating on compensation plan
Investing.com Analyst Ratings50 · neutralanalyst
Jul 21
Jul 21
Jul 20
Jul 18
Jul 17
Jul 1
Jul 1
Jun 18
Jun 3
Jun 3
Jun 3
Jun 2
Jun 2
Jun 2
Jun 1
Jun 1
Jun 1
May 28
May 28
May 20
May 14
May 14
May 14
May 14
Open KPTI in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →